NEW YORK (GenomeWeb News) – Orchid Cellmark today reported that its first-quarter revenues were down 3 percent, due to the adverse impact of foreign currency translation.

The Princeton, NJ-based DNA testing services firm brought in revenues of $14 million for the three-month period ended March 31, compared to revenues of $14.5 million for the first quarter of 2008. The company said that its revenues were up 13 percent year over year on a constant currency basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.